Skip to main content

Erasca, Inc.

ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001761918

No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Erasca, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
89
+9 vs. Q1 2022
Shares held
76.9M
+4.14M (+5.7%) vs. Q1 2022
Total value
$428.3M
−$197.7M (−31.6%) vs. Q1 2022
New holders
19
32 more added
Sold out
10
19 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 89 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 55 institutionsQ4 2021: 63 institutionsQ1 2022: 82 institutionsQ2 2022: 89 institutionsQ3 2022: 88 institutionsQ4 2022: 107 institutionsQ1 2023: 118 institutionsQ2 2023: 112 institutionsQ3 2023: 109 institutionsQ4 2023: 119 institutionsQ1 2024: 108 institutionsQ2 2024: 126 institutionsQ3 2024: 132 institutionsQ4 2024: 146 institutionsQ1 2025: 154 institutionsQ2 2025: 142 institutionsQ3 2025: 141 institutionsQ4 2025: 154 institutionsQ1 2026: 225 institutionsQ2 2026: 256 institutions
Value heldQ2 2022: $428.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $919.8MQ4 2021: $988.0MQ1 2022: $626.6MQ2 2022: $428.3MQ3 2022: $627.9MQ4 2022: $343.9MQ1 2023: $234.9MQ2 2023: $205.2MQ3 2023: $140.4MQ4 2023: $147.5MQ1 2024: $149.7MQ2 2024: $480.6MQ3 2024: $633.4MQ4 2024: $579.5MQ1 2025: $307.3MQ2 2025: $277.1MQ3 2025: $468.5MQ4 2025: $815.7MQ1 2026: $4.39BQ2 2026: $5.13B
Institutions holding ERAS and their total value by quarter
QuarterHoldersValue
Q2 2026256$5.13B
Q1 2026225$4.39B
Q4 2025154$815.7M
Q3 2025141$468.5M
Q2 2025142$277.1M
Q1 2025154$307.3M
Q4 2024146$579.5M
Q3 2024132$633.4M
Q2 2024126$480.6M
Q1 2024108$149.7M
Q4 2023119$147.5M
Q3 2023109$140.4M
Q2 2023112$205.2M
Q1 2023118$234.9M
Q4 2022107$343.9M
Q3 202288$627.9M
Q2 202289$428.3M
Q1 202282$626.6M
Q4 202163$988.0M
Q3 202155$919.8M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q1 2022.

Institutions holding ERAS in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Amalgamated Financial Corp.––––Not filed